Posted On: 09/25/2013 12:09:43 PM
Post# of 5066
Until BMSN officially puts out a PR that HemaX is approved for IND and P1 trials is gearing up, this will churn, assuming no other PR is released.
Today's PR is nice but then again, it isn't the key catalyst the stock needs to push up and away.
Today's PR is nice but then again, it isn't the key catalyst the stock needs to push up and away.
(0)
(0)Scroll down for more posts ▼
